Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01828021
Brief Title: Phase 2 Study of the Monoclonal Antibody MGAH22 (Margetuximab) in Patients With Relapsed or Refractory Advanced Breast Cancer

First Submitted : March 26, 2013
First Submitted that Met QC Criteria : April 5, 2013
First Posted : April 10, 2013 (Estimate)

Certification/Extension First Submitted : August 15, 2018
Certification/Extension First Submitted that Met QC Criteria : August 15, 2018
Certification/Extension First Posted : August 17, 2018

Last Update Submitted that Met QC Criteria : August 15, 2018
Last Update Posted : August 17, 2018